High Post-Treatment Leptin Concentration as a Prognostic Biomarker of the High Risk of Luminal Breast Cancer Relapse: A Six-Year Comprehensive Study.

Kwiatkowska, Katarzyna; Rhone, Piotr; Wrzeszcz, Katarzyna; Ruszkowska-Ciastek, Barbara

Kwiatkowska, Katarzyna; Rhone, Piotr; Wrzeszcz, Katarzyna; Ruszkowska-Ciastek, Barbara.

Afiliação

Kwiatkowska K; Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University, Collegium Medicum, 85-094 Bydgoszcz, Poland.
Rhone P; Clinical Ward of Breast Cancer and Reconstructive Surgery, Oncology Centre Prof. F. Lukaszczyk Memorial Hospital, 85-796 Bydgoszcz, Poland.
Wrzeszcz K; Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University, Collegium Medicum, 85-094 Bydgoszcz, Poland.
Ruszkowska-Ciastek B; Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University, Collegium Medicum, 85-094 Bydgoszcz, Poland.

Life (Basel) ; 12(12)2022 Dec 08.

Article em En | MEDLINE | ID: mdl-36556428

Palavras-chave

adiponectin; breast cancer; leptin; relapse; treatment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Life (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Polônia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google